Measles is highly contagious and causing significant outbreaks across the United States. Pennsylvania has experienced a surge, with over 1,000 cases reported in a week, following initial cases of 12. Nationwide, more than 4,000 measles cases have been reported this year, the highest in 35 years. Many communities are vulnerable due to declining vaccination rates. Individuals are urged to assess their immunity status.
Two doses of the measles, mumps, and rubella (MMR) vaccine are 97% effective, conferring lifelong immunity. However, those born before 1957 are presumed immune due to widespread childhood infection at the time. People vaccinated before 1968 may need an additional dose because of an earlier, less effective vaccine. Current recommendations emphasize two doses for children and adults, particularly those in higher-risk groups like healthcare workers, college students, and travelers.
If you are unsure of your immunization history, or only received one dose, consulting a doctor is recommended. Those in areas with high measles activity, or in close contact with immunocompromised individuals, should consider a second dose. Blood tests to check antibody levels are possible but not always definitive. Most private insurance plans and Medicaid must cover another MMR vaccine at no cost. It is generally easier and less expensive to receive another MMR vaccine than to undergo testing.
Regardless of age or immunization records, measles is a serious disease. Getting two doses of the vaccine offers protection and contributes to broader immunity, safeguarding vulnerable populations like pregnant women, severely immunocompromised individuals, and infants under 6 months of age.